Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine in Neurocutaneous Syndromes: Genotype-Guided Risk Stratification and Targeted Therapy Outcomes in a 20-Year Multicenter Cohort From Western China

NCT07327164 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07327164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07327164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine in Neurocutaneous Syndromes: Genotype-Guided Risk Stratification and Targeted Therapy Outcomes in a 20-Year Multicenter Cohort From Western China
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
April 1, 2025
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurocutaneous syndromes, neurofibromatosis type 1 (nf1), sturge-weber syndrome (sws), tuberous sclerosis complex (tsc), von hippel-lindau disease